PT - JOURNAL ARTICLE AU - Zaid, Younes AU - Puhm, Florian AU - Allaeys, Isabelle AU - Naya, Abdallah AU - Oudghiri, Mounia AU - Khalki, Loubna AU - Limami, Youness AU - Zaid, Nabil AU - Sadki, Khalid AU - El Haj, Rafiqua Ben AU - Maher, Wissal AU - Lamiae, Belayachi AU - Belefquih, Bouchra AU - Benouda, Amina AU - Cheikh, Amine AU - Cherrah, Yahia AU - Flamand, Louis AU - Guessous, Fadila AU - Boilard, Eric TI - Platelets can contain SARS-CoV-2 RNA and are hyperactivated in COVID-19 AID - 10.1101/2020.06.23.20137596 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.23.20137596 4099 - http://medrxiv.org/content/early/2020/06/23/2020.06.23.20137596.short 4100 - http://medrxiv.org/content/early/2020/06/23/2020.06.23.20137596.full AB - Rationale In addition to the overwhelming lung inflammation that prevails in COVID-19, hypercoagulation and thrombosis contribute to the lethality of subjects infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Platelets are chiefly implicated in thrombosis. Moreover, they can interact with viruses and are an important source of inflammatory mediators. While a lower platelet count is associated with severity and mortality, little is known about platelet function during COVID-19.Objective To evaluate the contribution of platelets to inflammation and thrombosis in COVID-19 patients.Methods and Results We document the presence of SARS-CoV-2 RNA in platelets of COVID-19 patients. Exhaustive assessment of cytokines in plasma and in platelets revealed the modulation of platelet-associated cytokine levels in COVID-19, pointing to a direct contribution of platelets to the plasmatic cytokine load. Moreover, we demonstrate that platelets release their alpha- and dense-granule contents and phosphatidylserine-exposing extracellular vesicles. Functionally, platelets were hyperactivated in COVID-19 subjects, with aggregation occurring at suboptimal thrombin concentrations. Furthermore, platelets adhered more efficiently onto collagen-coated surfaces under flow conditions.Conclusions These data suggest that platelets could participate in the dissemination of SARS-CoV-2 and in the overwhelming thrombo-inflammation observed in COVID-19. Thus, blockade of platelet activation pathways may improve outcomes in this disease.KEY POINTS Platelets are a source of inflammatory cytokines and degranulate in COVID-19 Platelets contain SARS-CoV-2 RNA molecules and are prone to activation in COVID-19Subject terms Infectious diseases/Emerging infectious diseases, SARS-CoV-2, COVID-19, Hematology, PlateletsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by Cheikh Zaid Foundation and the Canadian Institutes of Health Research (to LF). EB is recipient of senior award from the Fonds de Recherche du Quebec en Sante (FRQS). FP is recipient of a postdoctoral fellowship from FRQSAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Local Ethics Committee of Cheikh Zaid Hospital, Rabat, Morocco, Project: CEFCZ/PR/2020-PR04All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data, analytic methods and study materials supporting the findings of this study are provided in the manuscript, supplemental material and available from the corresponding author upon reasonable request.ACE2Angiotensin Converting Enzyme 2ALTAminotransferaseASTAspartate AminotransferaseCOVID-19Coronaviruse Disease 2019FDPFibrin Degradation ProductILInterleukinLDHLactate DehydrogenaseNETNeutrophil-extracellular trapPF4Platelet Factor 4PKCProtein kinase CPLRPlatelet-Lymphocyte RatioSARS-CoV-2Severe Acute Respiratory Syndrome Coronavirus 2TLRToll-like receptorTNFTumor Necrosis FactorTxB2Thromboxane B2